Structural and redox requirements for the action of anti-diabetic vanadium compounds
The transformation of non-oxido VIVto oxido VIVspecies under physiological conditions is necessary for a vanadium compound to exhibit pharmacological anti-diabetic activity.
2014 ◽
Vol 60
(4)
◽
pp. 416-429
◽
1974 ◽
Vol 32
◽
pp. 194-195
1990 ◽
Vol 48
(3)
◽
pp. 90-91
Keyword(s):
1993 ◽
Vol 70
(05)
◽
pp. 867-872
◽